SSII (SS Innovations) רווח נקי למניה (EPS TTM)

SS Innovations International (SSII) is focusing on expansion in India and FDA approval by utilizing aggressive dumping. The trailing twelve-month EPS serves as a confidence indicator, with the current parameter standing at -0.06. The Mantra robotic environment creates high switching costs through its software. The acquisition of the system locks clinics into purchasing consumables, ensuring one hundred percent customer retention.

The metric is calculated as the ratio of total net income over the last four quarters to the total number of shares, reflecting the actual profit attributable to a single security. The trend of the rolling annual earnings per share confirms the effectiveness of the pricing strategy of SS Innovations International (SSII), where the accessibility of the Mantra system combined with high quality stimulates demand and converts market advantage into growth in fundamental value.